| The decline in e-cigarette use among youth in the United States—an encouraging trend but an ongoing public health challenge BM Choi, I Abraham JAMA network open 4 (6), e2112464-e2112464, 2021 | 30 | 2021 |
| Treatment with pembrolizumab after hypersensitivity reaction to nivolumab in a patient with hepatocellular carcinoma B Choi, A McBride, AJ Scott American Journal of Health-System Pharmacy 76 (21), 1749-1752, 2019 | 23 | 2019 |
| Comparing jurisdiction-specific pharmaco-economic evaluations using medical purchasing power parities BM Choi, RB Abraham, H Halawah, M Calamia, M Obeng-Kusi, ... Journal of Medical Economics 24 (sup1), 34-41, 2021 | 9 | 2021 |
| Retrospective evaluation of safety and effectiveness of same-day pegfilgrastim in patients with lung cancer N Alrawashdh, J Vraney, BM Choi, AR Almutairi, I Abraham, A McBride Future Oncology 18 (19), 2381-2390, 2022 | 3 | 2022 |
| Comorbidities and perceived health status in persons with history of cancer in the USA M Obeng-Kusi, JL Vardy, ML Bell, BM Choi, DR Axon Supportive Care in Cancer 31 (1), 16, 2023 | 2 | 2023 |
| Association between Patient–Provider Communication and Self-Perceived Mental Health in US Adults with Cancer: Real-World Evidence through Medical Expenditure Panel Survey BM Choi, M Obeng-Kusi, DR Axon Diseases 10 (4), 88, 2022 | 2 | 2022 |
| Economic evaluation of six and 12 month (m) treatment with isatuximab and carfilzomib and dexamethasone (IKd) versus daratumumab and carfilzomib and dexamethasone (DKd) in … N AlRawashdh, B Choi, M Obeng-Kusi, M Calamia, A McBride, I Abraham Journal of Clinical Oncology 39 (15_suppl), e20010-e20010, 2021 | 2 | 2021 |
| Cost evaluation of adjunctive osimertinib use in resected epidermal growth factor receptor-positive non-small cell lung cancer. B Choi, N Alrawashdh, A McBride, I Abraham Journal of Clinical Oncology 39 (15_suppl), 8525-8525, 2021 | 2 | 2021 |
| Association of e-Cigarette Use and Postpartum Depression: Pregnancy Risk Assessment Monitoring System 2016–2019 BM Choi, AH Weinberger, N Petersen, RD Pang, EE DeVito, ML Bell, ... Journal of Women's Health 33 (1), 45-51, 2024 | 1 | 2024 |
| Network meta-analysis (NMA) of second-line (2L) treatment options in metastatic renal cell carcinoma. A Recio-Boiles, M Obeng-Kusi, B Choi, I Abraham Journal of Clinical Oncology 40 (6_suppl), 337-337, 2022 | 1 | 2022 |
| Institutional chart review on same-day pegfilgrastim administration in small cell lung cancer (SCLC) patients receiving myelotoxic chemotherapy. B Choi, N Alrawashdh, J Vraney, A McBride, I Abraham Journal of Clinical Oncology 39 (28_suppl), 71-71, 2021 | 1 | 2021 |
| An institutional evaluation of the safety and efficacy of same-day administration of pegfilgrastim in patients receiving chemotherapy for lung cancer. J Vraney, N AlRawashdh, B Choi, I Abraham, A McBride Journal of Clinical Oncology 39 (15_suppl), e18591-e18591, 2021 | 1 | 2021 |
| Economic evaluation crizotinib, alectinib and brigatinib in anaplastic lymphoma kinase positive (ALK+) non-small cell lung cancer (NSCLC). B Choi, NS Alkhatib, E Pae, HM Babiker, LL Garland, A Henglefelt, ... Journal of Clinical Oncology 37 (15_suppl), e20714-e20714, 2019 | 1 | 2019 |
| Acceptability of Hormonal Contraceptives as a Smoking Cessation Aid for Women of Reproductive Age: A Web-Based Cross-Sectional Survey SJ Werts-Pelter, BM Choi, S Mallahan, N Person-Rennell, A Allen Women's Health Reports 5 (1), 161-169, 2024 | | 2024 |
| Network meta-analysis of second line and beyond treatment options in metastatic clear cell renal cell carcinoma M Obeng-Kusi, JJ Kreutzfeldt, RJ Estrada-Mendizabal, BM Choi, ... Urologic Oncology: Seminars and Original Investigations 42 (2), 32. e1-32. e8, 2024 | | 2024 |
| Overall survival, efficacy, and safety outcomes beyond front-line modern therapies in metastatic clear-cell renal cell carcinoma. J Kreutzfeldt, M Obeng-Kusi, RJ Estrada-Mendizabal, BM Choi, I Abraham, ... Journal of Clinical Oncology 41 (6_suppl), 667-667, 2023 | | 2023 |
| EPH39 Association Between Patient-Physician Communication and Perceived Mental Health Status Among United States Adults With Cancer B Choi, D Axon Value in Health 25 (12), S198-S199, 2022 | | 2022 |
| Improving and validating a rating scale to assess student pharmacists’ perception of professional identity M Obeng-Kusi, BM Choi, DR Axon, J Cooley, T Warholak Journal of the American Pharmacists Association 62 (5), 1623-1630. e2, 2022 | | 2022 |
| Economic evaluations of adjunctive osimertinib treatment in surgically resected epidermal growth factor receptor positive (EGFR+) non-small cell lung cancer (NSCLC): Analysis … M Obeng-Kusi, BM Choi, RB Abraham, O Aqel, M Calamia, H Halawah, ... Journal of Clinical Oncology 40 (16_suppl), e20505-e20505, 2022 | | 2022 |
| Economic evaluations of adjunctive osimertinib treatment in surgically resected epidermal growth factor receptor positive (EGFR+) non-small cell lung cancer (NSCLC): Analysis … BM Choi, RB Abraham, O Aqel, US Agu, KC Gregory, M Obeng-Kusi, ... Journal of Clinical Oncology 40 (16_suppl), e20502-e20502, 2022 | | 2022 |
